Efficacy and tolerability of intravenous levetiracetam in children

Frontiers in Neurology

Volumn 4 AUG, Issue , 2013, Pages

  Aceves, Jose ^a   Khan, Owais ^b   Mungall, Diana ^c   Fonkem, Ekokobe ^d   Wright, Chanin ^a   Wenner, Andrea ^a   Kirmani, Batool ^d  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Epilepsy; Intractable epilepsy; Intravenous levetiracetam; Seizures; Status epilepticus

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; ETIRACETAM; PHENOBARBITAL;

ARTICLE; CHILD; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; EMERGENCY WARD; EPILEPTIC STATE; FOOD AND DRUG ADMINISTRATION; HOSPITAL ADMISSION; HUMAN; INFANTILE SPASM; INTRACTABLE EPILEPSY; MONOTHERAPY; SEIZURE; SOMNOLENCE; THERAPY DELAY;

EID: 84883535358     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2013.00120     Document Type: Article

References (37)

1. Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA (1993) 270:854-9. doi:10.1001/jama.270.7.854
2. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia (1999) 40:120-2. doi:10.1111/j.1528-1157.1999.tb02000.x
3. Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome and treatment. Epilepsia (1996) 37(Suppl l):S74-80. doi:10.1111/j.1528-1157.1996.tb06025.x
4. Lynch B, Lambeng N, Nocka K, Kensel-Hammes P, Baijalieh SM, Matagne A, et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A (2004) 101:9861-6. doi:10.1073/pnas.0308208101
5. Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia (2006) 47:1128-35. doi:10.1111/j.1528-1167.2006.00586.x
6. Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, et al. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther (2006) 28:734-44. doi:10.1016/j.clinthera.2006.05.004
7. Weinstock A, Ruiz M, Gerard D, Toublanc N, Stockis A, Farooq O, et al. Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of Intravenous levetiracetam in children with epilepsy. J Child Neurol (2013). [Epub ahead of print]. doi:10.1177/0883073813480241
8. Klitgaard H, Matagne A, Gobert J, Wülfert E. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy. Eur J Pharmacol (1998) 353:191-206. doi:10.1016/S0014-2999(98)00410-5
9. Mazarati AM, Baldwin R, Klitgaard H, Matagne A, Wasterlain CG. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus. Epilepsy Res (2004) 58:167-74. doi:10.1016/j.eplepsyres.2004.02.002
10. Baulac M, Brodie MJ, Elger CE, Krakow K, Stockis A, Mewisch P, et al. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia (2007) 48:589-92. doi:10.1111/j.1528-1167.2006.00959.x
11. Olson DM. Neonatal seizures. Neoreviews (2012) 13:e213-23. doi:10.1542/neo.13-4-e213
12. Thibeault-Eybalin MP, Lortie A, Carmant L. Neonatal seizures: do they damage the brain? Pediatr Neurol (2009) 40:175-80. doi:10.1016/j.pediatrneurol.2008.10.026
13. Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr (1999) 134:71-5. doi:10.1016/S0022-3476(99)70374-4
14. Cilio MR, Ferriero DM. Synergistic neuroprotective therapies in hypothermia. Semin Fetal Neonatal Med (2010) 15:293-8. doi:10.1016/j.siny.2010.02.002
15. Silverstein FS, Ferriero DM. Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol (2008) 39:77-9. doi:10.1016/j.pediatrneurol.2008.04.008
16. Kilicdag H, Daglioglu K, Erdogan S, Guzel A, Sencar L, Polat S, et al. The effect of levetiracetam on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev (2013) 89:355-60. doi:10.1016/j.earlhumdev.2012.12.002
17. Koppelstäetter A, Buhrer C, Kaindl AM. Treating neonates with levetiracetam: a survey among German University Hospitals. Klin Padiatr (2011) 223:450-2. doi:10.1055/s-0031-1287822
18. Painter MJ, Scher MS, Stein AD, Armatti S, Wang Z, Gardiner JC, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med (1999) 341:485-9. doi:10.1056/NEJM199908123410704
19. Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR. Levetiracetam for the treatment of neonatal seizures. J Child Neurol (2011) 26:465-70. doi:10.1177/0883073810384263
20. Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol (2011) 44:265-9. doi:10.1016/j.pediatrneurol.2010.11.005
21. Shoemaker MT, Rotenberg JS. Levetiracetam for the treatment of neonatal seizures. J Child Neurol (2007) 22:95-8. doi:10.1177/0883073807299973
22. Hmaimess G, Kadhim H, Nassogne MC, Bonnier C, van Rijckevorsel K. Levetiracetam in a neonate with malignant migrating partial seizures. Pediatr Neurol (2006) 34:55-9. doi:10.1016/j.pediatrneurol.2005.06.011
23. Ledet DS, Wheless JW, Rubnitz JE, Brannon Morris E. Levetiracetam as mono-therapy for seizures in a neonate with acute lymphoblastic leukemia. Eur J Paediatr Neurol (2010) 14:78-9. doi:10.1016/j.ejpn.2008.12.007
24. Furwentsches A, Bussman C, Ramantani G, Ebinger F, Philippi H, Poschl J, et al. Levetiracetam in the treatment of neonatal seizures: a pilot study. Seizure (2010) 19:185-9. doi:10.1016/j.seizure.2010.01.003
25. Ramantani G, Ikonomidou C, Walter B, Rating D, Dinger J. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol (2011) 15:1-7. doi:10.1016/j.ejpn.2010.10.003
26. Merhar SL, Schibler KR, Sherwin CM, Meinzen-Derr J, Shi J, Balmakund T, et al. Pharmacokinetics of levetiracetam in neonates with seizures. J Pediatr (2011) 159:152-4. doi:10.1016/j.jpeds.2011.03.057
27. Cilio MR, Bianchi R, Balestri M, Onofri A, Giovannini S, Di Capua M, et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res (2009) 86:66-71. doi:10.1016/j.eplepsyres.2009.05.004
28. Michaelides C, Thibert RL, Shapiro MJ, Kinirons P, John T, Manchharama D, et al. Tolerability and dosing experience of intravenous levetiracetam in children and infants. Epilepsy Res (2008) 81:143-7. doi:10.1016/j.eplepsyres.2008.05.004
29. Goraya JS, Khurana DS, Valencia I, Melvin JJ, Cruz M, Legido A, et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol (2008) 38:177-80. doi:10.1016/j.pediatrneurol.2007.11.003
30. Haberlandt E, Sigl SB, Scholl-Buergi S, Karall D, Rauchenzauner M, Rostasy K. Levetiracetam in the treatment of two children with myoclonic status epilepticus. Eur J Paediatr Neurol (2009) 13:546-9. doi:10.1016/j.ejpn.2008.09.006
31. Alehan F, Ozcay F, Haberal M. The use of levetiracetam in a child with nonconvulsive status epilepticus. J Child Neurol (2008) 23:331-3. doi:10.1177/0883073807309237
32. Weber P. Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome. J Child Neurol (2010) 25:393-6. doi:10.1177/0883073809338626
33. Kirmani BF, Crisp ED, Kayani S, Rajab H. Role of intravenous levetiracetam in acute seizure management of children. Pediatr Neurol (2009) 41:37-9. doi:10.1016/j.pediatrneurol.2009.02.016
34. Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med (2009) 10:505-10. doi:10.1097/PCC.0b013e3181a0e1cf
35. Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A. Levetiracetam monotherapy in children with epilepsy. Pediatr Neurol (2007) 36:227-30. doi:10.1016/j.pediatrneurol.2006.09.018
36. Gallentine WB, Hunnicutt AS, Husain AM. Levetiracetam in children with refractory status epilepticus. Epilepsy Behav (2009) 14:215-8. doi:10.1016/j.yebeh.2008.09.028
37. Li J, Xiao N, Chen S. Efficacy and tolerability of levetiracetam in children with epilepsy. Brain Dev (2011) 33:145-51. doi:10.1016/j.braindev.2010.03.002